121 related articles for article (PubMed ID: 12043232)
21. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
22. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies.
Beld M; Penning M; van Putten M; van den Hoek A; Lukashov V; McMorrow M; Goudsmit J
J Clin Microbiol; 1998 Oct; 36(10):3002-6. PubMed ID: 9738057
[TBL] [Abstract][Full Text] [Related]
25. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
26. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
27. Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection.
Negro F; Troonen H; Michel G; Giostra E; Albrecht M; Perrin L; Hadengue A
J Virol Methods; 1996 Jul; 60(2):179-82. PubMed ID: 8844624
[TBL] [Abstract][Full Text] [Related]
28. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
29. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
[TBL] [Abstract][Full Text] [Related]
30. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
Pereboeva LA; Pereboev AV; Morris GE
J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
[TBL] [Abstract][Full Text] [Related]
31. Isolate antibody to hepatitis C virus core antigen (C22) by RIBA-2: correlation with HCV-RNA and anti-NS5.
Taliani G; Badolato MC; Lecce R; Bruni R; Clementi C; Grimaldi F; Furlan C; Manganaro M; Duca F; Bozza A
Arch Virol Suppl; 1993; 8():219-28. PubMed ID: 8260866
[TBL] [Abstract][Full Text] [Related]
32. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
33. Perinatal transmission of hepatitis C antigens: envelope 1, envelope 2 and non-structural 4.
Attallah AM; Abdallah SO; El-Far M; Omran MM; Tabll AA; Ghaly MF; Ezzat SM; Elhamshary MO; El-Gohary ZM; Mohamedin AH; El-Morsi AA; Askora AA; Abdelrazek MA; El-Kafrawy HM; Keneber MH; Khalil MR; Aggag MM; Elbendary MS; El-Deeb MM; Abuzaid MS; Mansour AT; Attallah AA
Infect Dis (Lond); 2015 Aug; 47(8):568-74. PubMed ID: 25922972
[TBL] [Abstract][Full Text] [Related]
34. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
36. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.
Yoon SK; Park YM; Byun BH; Bae SH; Yang JM; Ahn BM; Lee YS; Lee CD; Sun HS; Kim BS
Korean J Intern Med; 2000 Jul; 15(2):109-16. PubMed ID: 10992722
[TBL] [Abstract][Full Text] [Related]
37. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
39. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
40. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
